LogiPharma Europe 2025: Three Ways to Turn Sustainability Pledges Into Progress
April 23rd 2025Joydeep Ganguly, SVP, corporate operations, interim CIO, Gilead Sciences, shares how stakeholders can drive meaningful, lasting impact by turning pledges into proof points, exercising patience, and embedding sustainability into core business operations.
LogiPharma Europe 2025: Driving Business Success Through Sustainability
April 22nd 2025Joydeep Ganguly, SVP, corporate operations, interim CIO, Gilead Sciences, shares insights on how sustainability has evolved from a compliance requirement to a key business strategy, driving operational efficiencies, innovation, and long-term growth.
PAP 2025: Why Patient Empowerment is Key
April 16th 2025In the final part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Rachel Thorpe, executive director at the Otsuka Patient Assistance Foundation, emphasizes the importance of the separation of core business and foundation, the value of patient empowerment, and the impact of digital innovation.
Hubs East 2025: Building a Thriving Culture
April 11th 2025In the final part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Kimberly Westrich, chief strategy officer at the National Pharmaceutical Council, comments on another presentation that has caught her eye at the conference.
LogiPharma Europe 2025: The Evolving Role of Operations in Advancing Therapeutic Delivery
April 10th 2025Steffen Lang, president, operations, executive committee member, Novartis, shares strategic insights on how pharma supply chain leaders can elevate operations to drive innovation, growth, and patient impact.
Hubs East 2025: Pushing Back Against Cost-Shifting Programs
April 10th 2025In the third part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Kimberly Westrich, chief strategy officer at the National Pharmaceutical Council, details the aspect of her presentation that she would have wanted to dive further into.
PAP 2025: Creating an Independent Patient Assistance Foundation
April 8th 2025In the second part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Rachel Thorpe, executive director at the Otsuka Patient Assistance Foundation, lays out the ways to begin transitioning a foundation.
Hubs East 2025: How Various Programs Affect Patient Care and Health Equity
April 7th 2025In the second part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Kimberly Westrich, chief strategy officer at the National Pharmaceutical Council, describes how accumulators, maximizers, and AFPs are impacting patients, manufacturers, and healthcare ecosystems, and how that all ties into the presentation she participated in.
PAP 2025: Establishing and Transitioning to a Foundation
April 3rd 2025In the first part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Rachel Thorpe, executive director at the Otsuka Patient Assistance Foundation, describes the various conference sessions that she participated in.
Hubs East 2025: Understanding Copay Accumulators, Maximizers, and Alternative Funding Programs
April 2nd 2025In the first part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Kimberly Westrich, chief strategy officer at the National Pharmaceutical Council, lays out the basics surrounding accumulators, maximizers, and AFPs.